New Technologies for Liver Disease SBIR (R43/R44)

The summary for the New Technologies for Liver Disease SBIR (R43/R44) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	New Technologies for Liver Disease SBIR (R43/R44)
	CFDA Number:	93.113
	CFDA Description:	Environmental Health
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Environment Food and Nutrition Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-09-095
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Feb 11, 2009
	Creation Date:	Feb 11, 2009
	Original Closing Date for Applications:	Jan 07, 2012
	Current Closing Date for Applications:	Jan 07, 2012
	Archive Date:	Feb 07, 2012
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Information not provided
Grant Description: Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to solicit Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop resources, research tools, instrumentations, biomarkers, devices, drugs or new and innovative approaches to diagnosis, monitoring, management, treatment and prevention of liver diseases.Areas of interest include development of reliable and practical means of diagnosis of liver diseases; biomarkers for disease activity and stage; noninvasive tests for inflammation, fibrosis and fat in the liver; and drugs, complementary and alternative modalities, biologics or molecular reagents for the therapy or prevention of liver diseases.The goal of this announcement is to enlist members of the small business research community in advancing means of diagnosis, treatment and prevention of liver disease and facilitate the goals outlined in the trans-NIH Action Plan for Liver Disease Research. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PAR-09-094, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/pa-09-095.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Research Project Grant (Parent R01); • Research on Research Integrity (R21); • Sleep and Social Environment: Basic Biopsychosocial Processes (R21); • Ethical Legal and Social Implications (ELSI) of Genomic Research Regular Research Program (R01); • Ethical, Legal, and Social Implications (ELSI) of Genomic Research Small Research Grant Program (R03...; • Outstanding New Environmental Scientist Award (ONES); • Environmental Health Sciences Core Center Grants; • LEIOMYOMATA UTERI: BASIC SCIENCE AND TRANSLATIONAL RESEARCH; • Disease Investigation through Specialized Clinically-Oriented Ventures in Environmental Research (DI...; • Comparative Biology Elucidation of Environmental Pathways and Susceptibility (R01)